Molecular Medicine |
From the Department of Pharmacology (M.G., R.N., J.N., S.V., D.P., V.K., D.M., A.B.M., T.V.-Y.), University of Illinois College of Medicine and Center for Lung and Vascular Biology, Chicago; the Department of Molecular Biology (J.M.), Osaka Medical Center for Cancer and Cardiovascular Diseases, and the Department of Molecular Biology and Biochemistry (Y.T.), Osaka University School of Medicine, Osaka, Japan.
Correspondence to Dr T. Voyno-Yasenetskaya, University of Illinois, Department of Pharmacology (MC 868), 835 S. Wolcott Ave, Chicago, IL 60612. E-mail tvy{at}uic.edu
Rho family GTPases have been implicated in the regulation of endothelial permeability via their actions on actin cytoskeletal organization and integrity of interendothelial junctions. In cell culture studies, activation of RhoA disrupts interendothelial junctions and increases endothelial permeability, whereas activation of Rac1 and Cdc42 enhances endothelial barrier function by promoting the formation of restrictive junctions. The primary regulators of Rho proteins, guanine nucleotide dissociation inhibitors (GDIs), form a complex with the GDP-bound form of the Rho family of monomeric G proteins, and thus may serve as a nodal point regulating the activation state of RhoGTPases. In the present study, we addressed the in vivo role of RhoGDI-1 in regulating pulmonary microvascular permeability using RhoGDI-1/ mice. We observed that basal endothelial permeability in lungs of RhoGDI-1/ mice was 2-fold greater than wild-type mice. This was the result of opening of interendothelial junctions in lung microvessels which are normally sealed. The activity of RhoA (but not of Rac1 or Cdc42) was significantly increased in RhoGDI-1/ lungs as well as in cultured endothelial cells on downregulation of RhoGDI-1 with siRNA, consistent with RhoGDI-1mediated modulation RhoA activity. Thus, RhoGDI-1 by repressing RhoA activity regulates lung microvessel endothelial barrier function in vivo. In this regard, therapies augmenting endothelial RhoGDI-1 function may be beneficial in reestablishing the endothelial barrier and lung fluid balance in lung inflammatory diseases such as acute respiratory distress syndrome.
Key Words: RhoGDI Rho GTPase endothelial permeability lung perfusion
Related Article:
Circ. Res. 2007 101: 7-9.
This article has been cited by other articles:
![]() |
M. Gorovoy, J. Han, H. Pan, E. Welch, R. Neamu, Z. Jia, D. Predescu, S. Vogel, R. D. Minshall, R. D. Ye, et al. LIM Kinase 1 Promotes Endothelial Barrier Disruption and Neutrophil Infiltration in Mouse Lungs Circ. Res., September 11, 2009; 105(6): 549 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elfenbein, J. M. Rhodes, J. Meller, M. A. Schwartz, M. Matsuda, and M. Simons Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKC{alpha} in a Rac1 activation pathway J. Cell Biol., July 13, 2009; 186(1): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moissoglu, K. S. McRoberts, J. A. Meier, D. Theodorescu, and M. A. Schwartz Rho GDP Dissociation Inhibitor 2 Suppresses Metastasis via Unconventional Regulation of RhoGTPases Cancer Res., April 1, 2009; 69(7): 2838 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Mong and Q. Wang Activation of Rho Kinase Isoforms in Lung Endothelial Cells during Inflammation J. Immunol., February 15, 2009; 182(4): 2385 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gien, G. J. Seedorf, V. Balasubramaniam, N. Tseng, N. Markham, and S. H. Abman Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L680 - L687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramchandran, D. Mehta, S. M. Vogel, M. K. Mirza, P. Kouklis, and A. B. Malik Critical role of Cdc42 in mediating endothelial barrier protection in vivo Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L363 - L369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. van Nieuw Amerongen and V. W.M. van Hinsbergh Endogenous RhoA Inhibitor Protects Endothelial Barrier Circ. Res., July 6, 2007; 101(1): 7 - 9. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |